111Indium-capromab pendetide unexpectedly localizes to renal cell carcinoma

Journal of Urology

Volumn 161, Issue 2, 1999, Pages 597-598

  Michaels, Eli K ^a   Blend, Michael ^a   Quintana, Juan Carlos ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Carcinoma, renal cell; Indium; Prostate; Prostatic neoplasms

Indexed keywords

CAPROMAB PENDETIDE; DIAGNOSTIC AGENT; INDIUM; MONOCLONAL ANTIBODY;

AGED; ARTICLE; CASE REPORT; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; SCINTISCANNING;

AGED; ANTIBODIES, MONOCLONAL; CARCINOMA, RENAL CELL; HUMANS; INDIUM RADIOISOTOPES; KIDNEY NEOPLASMS; MALE;

EID: 0033074325     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)61960-8     Document Type: Article

References (3)

1. Sychra, J. J., Lin, K. and Blend, M. J.: The detection of metastatic prostate cancer with simultaneous dual isotope SPECT images. RSNA. ORG/EJ. vol. 1, September 11, 1997.
2. Greenberg, R. S., Rustin, E. D. and Clark, W. S.: Risk of genitourinary malignancies after cancer of the prostate. Cancer, 61: 396, 1988.
3. Liu, H., Moy, P. and Kim, S.: Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res., 9: 3629, 1997.